IMVT
Immunovant Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$24.41
-0.58 ▼ -2.32%
🌙 3월 13일 7:17 PM ET (한국 3/14 08:17)
$24.89
+0.48 ▲ +1.97%
| Index | RUT | P/E | - | EPS (ttm) | -2.68 | Insider Own | 58.71% | Shs Outstand | 0.20B | Perf Week | -8.44% |
| Market Cap | 4.97B | Forward P/E | - | EPS next Y | 3.52% | Insider Trans | 16.12% | Shs Float | 0.08B | Perf Month | -5.9% |
| Enterprise Value | 3.97B | PEG | - | EPS next Q | -0.61 | Inst Own | 52.62% | Short Float | 20.03% | Perf Quarter | 3.61% |
| Income | -0.46B | P/S | - | EPS this Y | 2.5% | Inst Trans | 5.74% | Short Ratio | 11.49 | Perf Half Y | 45.3% |
| Sales | 0.00B | P/B | 5.03 | EPS next 5Y | 4.39% | ROA | -63.01% | Short Interest | 16.84M | Perf YTD | -3.97% |
| Book/sh | 4.85 | P/C | 5 | EPS past 3/5Y | -24.09% -12.18% | ROE | -69.35% | 52W High | -16.55% ($29.25) | Perf Year | 29.91% |
| Cash/sh | 4.89 | P/FCF | - | Sales past 3/5Y | - | ROIC | -47.07% | 52W Low | 91.9% ($12.72) | Perf 3Y | 54.49% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -2.53% | Gross Margin | - | Volatility(W/M) | 4.86% 4.34% | Perf 5Y | 43.67% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.23 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 15.74 | EPS Q/Q | 19.41% | Profit Margin | - | RSI (14) | 34.01 | Recom | 1.47 |
| Dividend Gr. 3/5Y | - | Current Ratio | 15.74 | Sales Q/Q | - | SMA20 | -7.99% ($26.53) | Beta | 0.66 | Target Price | $41.12 |
| Payout | - | Debt/Eq | 0 | Earnings | 2000000 | SMA50 | -7.09% ($26.27) | Rel Volume | 0.76 | Prev Close | $24.99 |
| Employees | 362 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 14.49% - | SMA200 | 18.69% ($20.57) | Avg Volume(3M) | 1.47M | Price | $24.41 |
| IPO | 2019/6/21 | Option/Short | Yes/Yes | Trades | 10668 | Volume | 1,106,627 | Change | -2.32% |
뉴스 로딩 중...